Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Alfacell licenses U.S. commercial rights to Onconase to Strativa Pharmaceuticals

Jan. 17, 2008

FDA grants approval to DAKO to market the TOP2A FISH pharmDx breast-cancer test

Jan. 17, 2008

Phase II trial of Hsp90 inhibitor alvespimycin begins in HER2+ metastatic breast cancer

Jan. 17, 2008

MicroRNA mimics suppress Bcr-Abl expression in vitro and in vivo

Jan. 17, 2008

BioCancell receives FDA approval for phase IIb bladder cancer study

Jan. 16, 2008

Protherics and Advancell enroll first patient in B-cell lymphocytic leukemia study

Jan. 15, 2008

Pharmion submits E.U. MAA for Vidaza in patients with MDS

Jan. 15, 2008

FDA extends review of Genasense NDA appeal

Jan. 15, 2008

Adventrx reports ANX-530 safety data and plans NDA submission

Jan. 15, 2008

The immunosuppressant FTY-720 shows promise in hematological cancer

Jan. 15, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026